FDAFDA · Food and drugs·Recall number D-096-2013
Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01
Published December 26, 2012 · Recall initiated: November 21, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- NALBUPHINE HYDROCHLORIDE
- Manufacturer
- Hospira, Inc.
- Distributor
- Nationwide and Puerto Rico.
- Lot
- Lot #: 11-293-DK, Exp 05/01/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.